In another study, the Cetuximab (C225)-immunoliposomes (ILs) encapsulating boron anion were constructed by using novel maleimido–Polyethylene Glycol (PEG)–cholesterol for the targeted delivery of boron compounds to EGFR (+) glioma cells for boron neutron capture therapy (BNCT). The gene discussed is EGFR; the disease is glioma.